Table of Contents

01 Executive Summary
  The Brain Industry Revealed
  Investment Risks and Opportunities
  Neurotechnology and Society
  Key Industry Facts and Findings
  Timeline of Advances in Neuroscience

02 Trends and Drivers
  Converging Technologies
  - Stem Cells and Neuroregeneration
  - Neuroimaging and Disease Treatment
  - Crossing the Blood Brain Barrier
  Demographic Drivers
  - More People Living Longer
  Social Drivers
  - The Life Style Improvement Market
  Economic Drivers
  - Worldwide Economic Burden
  - Rising Healthcare Costs
  Research Funding
  - United States Government
  - International Research Funding
  - Foundations Focus on the Brain
  Regulatory Trends
  - International Regulatory Competition
  Intellectual Property Trends
  - Global Intellectual Property Protection
  - Neuropharmaceutical Patent Expirations
  - Patent Activity in the US: 1980-2004
  - Selected Neurotechnology Patents

03 Neuropharmaceutical Sector
Cogniceutical Market
  - Alzheimer's Disease
  - Mild Cognitive Impairment
  - Attention Deficit Disorders
  - Sleep Disorders
  Emoticeutical Market
  - Depression
  - Anxiety Disorders
  Sensoceutical Market
  - Chronic Pain
  - Retinal and Optic Nerve Disorders
  - Epilepsy and Seizure Disorders
  - Parkinson's Disease
  Other Markets
  - Schizophrenia and Psychosis
  - Addiction and Substance Abuse

04 Neurodevice Sector
  Neuroprosthetic Devices
  - Cochlear Implants
  - Retinal Implants
  - Motor Prostheses & Brain-Computer Interface
  Neurostimulation Devices
  - Brain Stimulation
  - Spinal Cord Stimulation
  - Vagus Nerve Stimulation
  - Peripheral Nerve Stimulation
  Neurosurgical Devices
  - Neurosurgical Navigation Equipment
  - Radiosurgical Devices
  - Neurovascular Intervention
  Neurofeedback
  - Attention Deficit Disorders
  - Pain Control
  - Age-related Disorders

05 Neurodiagnostic Sector
Neuroimaging
  - Computed Tomography (CT)
  - Magnetic Resonance Imaging (MRI, fMRI)
  - Nuclear Medicine Imaging (PET, SPECT)
  - Electroencephalography (EEG)
  - Magnetoencephalography (MEG)
  In Vitro Diagnostics
  - Genetic Testing and Pharmacogenomics
  - Protein Biomarker Assays
  Neuroinformatics
  - Patient Dataset Management
  - Open Source Software

06 Private Neurotech Investment
  - U.S. Venture Capital Investment 1999-2004
  - Neurotech Venture Capital 1999-2004
  - Largest Neurotech Investments 1999-2004
  - Leading Neurotech Venture Capital Firms

07 Public Neurotech Investment
  - Neurotech Initial Public Offerings 2004
  - Recent Neurotech M&A activity
  - Neuropharma Research and Licensing Deals
  - NeuroInsights' Neurotech Index
  - Neurotech Index Performance

08 Leading Research Centers
University of California, San Francisco (UCSF)
Massachusetts Institute of Technology (MIT)
University of California, San Diego (UCSD)
Harvard University
Stanford University
University of California, Los Angeles (UCLA)
Columbia University
University College London (UCL)
Karolinska Institutet, Stockholm
RIKEN Brain Science Institute, Japan 
Places to Watch

09 Company Profiles
  Neuropharmaceutical Companies
  Neuropharmaceutical Delivery Companies
  Neuroregeneration Companies
  Neurodevice Companies
  Neurodiagnostic Companies